Stachyose

Star0

DB19276ExperimentalSmall molecule

Stachyose: Overview.

Formula / weight: C₂₄H₄₂O₂₁ · 666.579 g/mol (avg)
Also known as: .alpha.-d-glucopyranoside, .beta.-d-fructofuranosyl o-.alpha.-d-galactopyranosyl-(1->6)-o-.alpha.-d-galactopyranosyl-(1->6)- · Gal(.alpha.1->6)gal(.alpha.1->6)glc(.alpha.1->2.beta.)fru

Resolves to

Compound

UNII25VX64653NCAS470-55-3

Structure

InChIKeyUQZIYBXSHAGNOE-SWXGLOGKSA-NSMILES

[H][C@]1(O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@H](CO[C@H]2O[C@H](CO[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O

What you can answer from here — as of September 21, 2026

5+ReferencesStructured and connected to the statements they support

Which companies are running trials of Stachyose, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account